Featuring Todd Cartee, MD Mohs surgeon Dr. Cartee provided a comprehensive overview of cutaneous oncology in one of the afternoon breakout sessions. Incidence of non-melanoma skin cancers is increasing in patients under 40 years of age in the US. High risk basal cell cancers include micronodular, infiltrating and morpheaform subtypes. Morpheaform basal cell carcinomas tend …
Featuring Ginette Okoye, MD and Temitayo Ogunleye, MD Saturday morning began with an enlightening conversation with Dr. Ginette Okoye and Dr. Temitayo Ogunleye reviewing medical literature on skin of color. While this is improving, Dr. Okoye mentioned “ there is not a lot of great research in skin of color”. Dr. Ogunleye presented a review …
Featuring Dr. Jennie Clarke and Dr. Joslyn Kirby This morning Dr. Jennie Clarke and Dr. Joslyn Kirby gave a wonderful presentation reviewing pertinent medical literature from the last year applicable to current dermatology practice. Confirming what most in the dermatology field already believed, a recent JAMA Dermatology article revealed total unprotected sun exposure is significantly …
Some studies have suggested that female sex hormones may play a role in the development of malignant melanoma (MM). Though the data is far from conclusive, melanocytes appear to be hormonally responsive and there is the presence of estrogen receptors in melanocytic nevi and some melanoma cells. It is not known yet what contribution, if …
While skin cancer in children and adolescents remains rare, little is known about the burden of skin cancer on this population, including survival rates, and whether there are disparities among children with skin cancer. A recent population-based study examined a Florida cancer registry over the years 1981-2013, and the associated Census data to better describe …